SKYSTAR Trademark

Trademark Overview

On Thursday, March 17, 2022, a trademark application was filed for SKYSTAR with the United States Patent and Trademark Office. The USPTO has given the SKYSTAR trademark a serial number of 97316737. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Thursday, October 31, 2024. This trademark is owned by Skyhawk Therapeutics, Inc.. The SKYSTAR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, small molecule therapeutic preparations for the correction of RNA expression, used in the treatment of cancers, and other diseases, namely, cardiovascular diseases, immunological diseases, autoimmune diseases, neuromuscular diseases, blood disorders, rare genetic disorders and fibrosis; pharmaceuticals used in the treatment of cancers, and other diseases, namely, cardiovascular diseases, immunological diseases, autoimmune diseases, neuromuscular diseases, blood disorders, rare genetic disorders and fibrosis
skystar

General Information

Serial Number97316737
Word MarkSKYSTAR
Filing DateThursday, March 17, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateThursday, October 31, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 16, 2023

Trademark Statements

Goods and ServicesPharmaceuticals, namely, small molecule therapeutic preparations for the correction of RNA expression, used in the treatment of cancers, and other diseases, namely, cardiovascular diseases, immunological diseases, autoimmune diseases, neuromuscular diseases, blood disorders, rare genetic disorders and fibrosis; pharmaceuticals used in the treatment of cancers, and other diseases, namely, cardiovascular diseases, immunological diseases, autoimmune diseases, neuromuscular diseases, blood disorders, rare genetic disorders and fibrosis
Pseudo MarkSKY STAR

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 22, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSkyhawk Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451
Party NameSkyhawk Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451

Trademark Events

Event DateEvent Description
Tuesday, March 22, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 21, 2022NEW APPLICATION ENTERED
Thursday, December 29, 2022ASSIGNED TO EXAMINER
Thursday, January 5, 2023NON-FINAL ACTION WRITTEN
Thursday, January 5, 2023NON-FINAL ACTION E-MAILED
Thursday, January 5, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 22, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 22, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 22, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 11, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 16, 2023PUBLISHED FOR OPPOSITION
Wednesday, April 26, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 16, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 11, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, January 4, 2024SOU TEAS EXTENSION RECEIVED
Saturday, January 6, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 4, 2024SOU EXTENSION 1 FILED
Thursday, January 4, 2024SOU EXTENSION 1 GRANTED
Tuesday, February 20, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 20, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, February 20, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, February 26, 2024TEAS REQUEST TO DIVIDE RECEIVED
Friday, March 15, 2024DIVISIONAL PROCESSING COMPLETE
Wednesday, February 28, 2024DIVISIONAL REQUEST RECEIVED
Friday, March 15, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, June 24, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, March 16, 2024CORRECTED NOA E-MAILED
Monday, June 24, 2024SOU TEAS EXTENSION RECEIVED
Monday, June 24, 2024SOU EXTENSION 2 FILED
Thursday, October 31, 2024SOU TEAS EXTENSION RECEIVED
Thursday, October 31, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 31, 2024SOU EXTENSION 3 FILED
Thursday, October 31, 2024SOU EXTENSION 3 GRANTED
Monday, June 24, 2024SOU EXTENSION 2 GRANTED

Related Keywords

skystar diseases disorders namely autoimmune immunological cardiovascular neuromuscular blood genetic rare